Janssen W C, Rouwen J A, Hoffmann J J
Department of Clinical Laboratories, Catharina Hospital, Eindhoven, The Netherlands.
Ann Clin Biochem. 1992 Nov;29 ( Pt 6):663-7. doi: 10.1177/000456329202900608.
HLA-B27 is a cell marker of clinical interest because of its high association with certain diseases. The HLA-B27 antigen was detected on lymphocytes using a monoclonal antibody in an indirect immuno-fluorescence assay using a fluorescence flow cytometer. The considerable crossreaction of the monoclonal antibody with the HLA-B7 antigen was effectively suppressed by masking it by means of human anti-HLA-B7 antiserum. The flow cytometric method was evaluated by comparing the results with those obtained by the standard lymphocytotoxicity test and showed complete agreement in 107 selected patient samples.